• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Enoxaparin is a low-molecular-weight heparin with a complex chemical structure and various non-anticoagulant properties].

作者信息

Zyryanov S K, Ushkalova E A

机构信息

Peoples' Friendship University of Russia, Moscow, Russia.

出版信息

Ter Arkh. 2016;88(12):109-115. doi: 10.17116/terarkh20168812109-115.

DOI:10.17116/terarkh20168812109-115
PMID:28635885
Abstract

The paper discusses the non-anticoagulant properties of unfractionated heparin and enoxaparin and their relation to their chemical structures. It is emphasized that enoxaparin has multiple, often interrelated, non-anticoagulant effects that can complement its antithrombotic activity and enhance the efficiency of therapy in patients receiving the drug for various indications. The realization of these effects requires the complex structure with the standard distribution of molecular weight (Mw) (average Mw, about 4500 Da, as well as Mw of less than 2000 Da (<20%), 2000 to 8000 Da (>68%), and more than 8000 Da (<18%), and with the standard content of 1.6-anhidro rings (15-25%), which is determined by the source of raw materials and by the production technology of the original drug and cannot be fully reproduced when designing its bioanalogues.

摘要

相似文献

1
[Enoxaparin is a low-molecular-weight heparin with a complex chemical structure and various non-anticoagulant properties].
Ter Arkh. 2016;88(12):109-115. doi: 10.17116/terarkh20168812109-115.
2
Ion exchange chromatographic separation and isolation of oligosaccharides of intact low-molecular-weight heparin for the determination of their anticoagulant and anti-inflammatory properties.离子交换色谱分离和完整低分子量肝素寡糖的分离,以确定其抗凝和抗炎特性。
Anal Bioanal Chem. 2013 Jul;405(18):6043-52. doi: 10.1007/s00216-013-6996-9. Epub 2013 May 28.
3
Pharmacology department.药理学系。
J Cardiovasc Nurs. 2001 Jul;15(4):91-5. doi: 10.1097/00005082-200107000-00008.
4
Comparative pharmacodynamic assessment of the antiangiogenesis activity of heparin and low-molecular-weight heparin fractions: structure-function relationship.肝素和低分子量肝素片段的抗血管生成活性的比较药效学评估:结构-功能关系。
Clin Appl Thromb Hemost. 2013 Jan-Feb;19(1):48-54. doi: 10.1177/1076029611436194. Epub 2012 Feb 12.
5
Preparation and evaluation a new generation of low molecular weight heparin.新一代低分子量肝素的制备与评价
Biomed Pharmacother. 2016 Apr;79:194-200. doi: 10.1016/j.biopha.2016.02.021. Epub 2016 Mar 9.
6
Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.普通肝素和低分子量肝素(依诺肝素)对培养的人内皮细胞凝血活性的影响。
Haematologica. 2003 Jun;88(6):694-9.
7
Production method affects the pharmacokinetic and ex vivo biological properties of low molecular weight heparins.生产方法会影响低分子量肝素的药代动力学和体外生物学特性。
Thromb Haemost. 1997 Feb;77(2):317-22.
8
Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.硫酸皮肤素和低分子量肝素增强活化蛋白C的抗凝作用。
Thromb Haemost. 1999 Nov;82(5):1462-8.
9
Anticoagulant prescribing practices and anesthetic interventions among anticoagulated pregnant patients: a retrospective study.抗凝治疗的孕妇的抗凝药物处方实践及麻醉干预:一项回顾性研究。
Int J Obstet Anesth. 2014 Aug;23(3):238-45. doi: 10.1016/j.ijoa.2014.03.007. Epub 2014 Mar 28.
10
Non-anticoagulant effects of low molecular weight heparins in inflammatory disorders: A review.低分子肝素在炎症性疾病中的非抗凝作用:综述。
Carbohydr Polym. 2017 Mar 15;160:71-81. doi: 10.1016/j.carbpol.2016.12.037. Epub 2016 Dec 21.